In conclusion, our study demonstrates for the first time the potential prognostic role of an ARG signature in HCC, although more in-depth mechanisms and prognostic roles for this signature in HCC need to be confirmed in the future, our findings provide a preliminary basis to explore ARGs as a potential molecular target for the development of HCC therapies. This evidence concerns the gene SERPINA2 and hepatocellular carcinoma.